Table 1 |
||||
|
Demographic data |
||||
|
Controls (n = 86) |
Patients with SSc (n = 129) |
Patients with dcSSc (n = 50) |
Patients with lcSSc (n = 79) |
|
|
|
||||
|
Age in years, median (range) |
43 (19-64) |
53 (21-82) |
51 (21-65) |
55 (21-82) |
|
Females, percentage |
30 |
85 |
78 |
88 |
|
Ethnicity |
||||
|
Caucasian |
100% |
71% |
68% |
75% |
|
African-American |
14% |
14% |
13% |
|
|
Other |
15% |
18% |
12% |
|
|
Disease duration |
N/A |
|||
|
0-18 months |
19% |
36% |
9% |
|
|
19-36 months |
10% |
12% |
9% |
|
|
> 36 months |
71% |
52% |
82% |
|
|
MRSS from 0 to 51, median (range) |
N/A |
6 (2-45) |
16 (2-45) |
4 (2-25) |
|
BMI in kg/m2, median (range) |
N/A |
25 (14-48) |
25 (18-39) |
25 (14-48) |
|
|
||||
|
BMI, body mass index; dcSSc, diffuse cutaneous systemic sclerosis; lcSSc, limited cutaneous systemic sclerosis; MRSS, modified Rodnan skin score; N/A, not applicable; SSc, systemic sclerosis. |
||||
|
Lakota et al. Arthritis Research & Therapy 2012 14:R102 doi:10.1186/ar3827 |
||||
